G Spies1, L Asmal, S Seedat. 1. South African Research Chairs Initiative (SARChI), PTSD program, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa.
Abstract
BACKGROUND: Mood and anxiety disorders are highly prevalent and comorbid with HIV/AIDS. However, there is a paucity of research on the effectiveness of cognitive-behavioural interventions (CBI) for common mental disorders in HIV-infected adults. The present study sought to review the existing literature on the use of CBI for depression and anxiety in HIV-positive adults and to assess the effect size of these interventions. METHODS: We did duplicate searches of databases (from inception to 17-22 May 2012). The following online databases were searched: PubMed, The Cochrane Central Register of Controlled Trials and PsychArticles. RESULTS: We identified 20 studies suitable for inclusion. A total of 2886 participants were enroled in these studies, of which 2173 participants completed treatment. The present review of the literature suggests that CBI may be effective in the treatment of depression and anxiety in individuals living with HIV/AIDS. Significant reductions in depression and anxiety were reported in intervention studies that directly and indirectly targeted depression and/or anxiety. Effect sizes ranged from 0.02 to 1.02 for depression and 0.04 to 0.70 for anxiety. LIMITATIONS: Some trials included an immediate postintervention assessment but no follow-up assessments of outcome. This omission makes it difficult to determine whether the intervention effects are sustainable over time. CONCLUSION: The present review of the literature suggests that CBI may have a positive impact on the treatment of depression and anxiety in adults living with HIV/AIDS.
BACKGROUND: Mood and anxiety disorders are highly prevalent and comorbid with HIV/AIDS. However, there is a paucity of research on the effectiveness of cognitive-behavioural interventions (CBI) for common mental disorders in HIV-infected adults. The present study sought to review the existing literature on the use of CBI for depression and anxiety in HIV-positive adults and to assess the effect size of these interventions. METHODS: We did duplicate searches of databases (from inception to 17-22 May 2012). The following online databases were searched: PubMed, The Cochrane Central Register of Controlled Trials and PsychArticles. RESULTS: We identified 20 studies suitable for inclusion. A total of 2886 participants were enroled in these studies, of which 2173 participants completed treatment. The present review of the literature suggests that CBI may be effective in the treatment of depression and anxiety in individuals living with HIV/AIDS. Significant reductions in depression and anxiety were reported in intervention studies that directly and indirectly targeted depression and/or anxiety. Effect sizes ranged from 0.02 to 1.02 for depression and 0.04 to 0.70 for anxiety. LIMITATIONS: Some trials included an immediate postintervention assessment but no follow-up assessments of outcome. This omission makes it difficult to determine whether the intervention effects are sustainable over time. CONCLUSION: The present review of the literature suggests that CBI may have a positive impact on the treatment of depression and anxiety in adults living with HIV/AIDS.
Authors: J C Markowitz; J H Kocsis; B Fishman; L A Spielman; L B Jacobsberg; A J Frances; G L Klerman; S W Perry Journal: Arch Gen Psychiatry Date: 1998-05
Authors: Michael Mugavero; Jan Ostermann; Kathryn Whetten; Jane Leserman; Marvin Swartz; Dalene Stangl; Nathan Thielman Journal: AIDS Patient Care STDS Date: 2006-06 Impact factor: 5.078
Authors: Lorraine Sherr; Claudine Clucas; Richard Harding; Elissa Sibley; Jose Catalan Journal: Psychol Health Med Date: 2011-08-02 Impact factor: 2.423
Authors: Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer Journal: Health Psychol Date: 2009-01 Impact factor: 4.267
Authors: Simona Berger; Tanja Schad; Viktor von Wyl; Ulrike Ehlert; Claudine Zellweger; Hansjakob Furrer; Daniel Regli; Pietro Vernazza; Bruno Ledergerber; Manuel Battegay; Rainer Weber; Jens Gaab Journal: AIDS Date: 2008-03-30 Impact factor: 4.177
Authors: Michael Alan Horberg; Michael Jonah Silverberg; Leo Bartemeier Hurley; William James Towner; Daniel Benjamin Klein; Susan Bersoff-Matcha; Winkler Gabriel Weinberg; Diana Antoniskis; Miguel Mogyoros; Wayne Thomas Dodge; Robert Dobrinich; Charles Price Quesenberry; Drew Anthony Kovach Journal: J Acquir Immune Defic Syndr Date: 2008-03-01 Impact factor: 3.731
Authors: M H Antoni; L Baggett; G Ironson; A LaPerriere; S August; N Klimas; N Schneiderman; M A Fletcher Journal: J Consult Clin Psychol Date: 1991-12
Authors: Kelly C Young-Wolff; Varada Sarovar; Stacy A Sterling; Amy Leibowitz; Brigid McCaw; Charles B Hare; Michael J Silverberg; Derek D Satre Journal: AIDS Care Date: 2019-03-19
Authors: Tracie M Goodness; Tibor P Palfai; Debbie M Cheng; Sharon M Coleman; Carly Bridden; Elena Blokhina; Evgeny Krupitsky; Jeffrey H Samet Journal: AIDS Behav Date: 2014-06
Authors: Charles Brandt; Michael J Zvolensky; Steven P Woods; Adam Gonzalez; Steven A Safren; Conall M O'Cleirigh Journal: Clin Psychol Rev Date: 2016-11-17
Authors: Etheldreda Nakimuli-Mpungu; Colin M Smith; Kizito Wamala; James Okello; Josephine Birungi; Micheal Etukoit; Ramin Mojtabai; Jean B Nachega; Ofir Harari; Seggane Musisi; Edward J Mills Journal: Psychosom Med Date: 2022-09-06 Impact factor: 3.864
Authors: Abigail M Hatcher; Emiliano Lemus Hufstedler; Kathryne Doria; Shari L Dworkin; Elly Weke; Amy Conroy; Elizabeth A Bukusi; Craig R Cohen; Sheri D Weiser Journal: Transcult Psychiatry Date: 2019-06-26
Authors: Kathleen J Sikkema; Alexis C Dennis; Melissa H Watt; Karmel W Choi; Tatenda T Yemeke; John A Joska Journal: Glob Ment Health (Camb) Date: 2015-09-09